Clinical Trials - Bringing novel diagnostics and therapies directly to patients

NAZ 3982 240320 Y

Clinical trials give patients access to innovative treatment approaches and new therapeutic options that are not yet widely available. At CCCZ, they play a key role in advancing cancer care and accelerating the translation of scientific discoveries into clinical practice.

By closely integrating research and patient care, our clinical trials offer access to cutting-edge therapies while ensuring the highest standards of safety and quality. Patients benefit from comprehensive support by experienced multidisciplinary teams and contribute to the development of tomorrow’s cancer treatments.

CCCZ Trial Finder

Looking for clinical trials for children or adults with cancer? Use our Trial Finder to explore oncology studies across the University Hospitals of Zurich and find the right contact person for support.

Trial ICON

Why Take Part in a Clinical Trial?

  • Access to innovative treatments that may not yet be widely available

  • Treatment based on the latest scientific standards and current medical knowledge

  • Close medical monitoring with frequent check-ups and additional examinations

  • Expert care by a specialized study team throughout the trial

  • No additional costs for study-related treatments and examinations

  • Contribution to progress in cancer medicine, helping future patients

  • Voluntary participation with the option to withdraw at any time without disadvantages

Patientin AML

Patient Story

Learn how personalized drug testing is used to guide treatment decisions—and discover how clinical trials are shaping more precise, patient-centered leukemia care.

“With more than 90 interventional trials, we expand treatment options for cancer patients through innovative therapies that are not yet available outside clinical studies. Investigator-initiated trials (IITs) enable the direct translation of the latest scientific discoveries from CCCZ into clinical practice, making the program unique in the Zurich region.”

Alexandre Theocharides, Prof. Dr. med. - Director CCCZ Clinical Trial Program

Alexandre Theocharides 2035

CCCZ Clinical Trial program

CCCZ coordinates a comprehensive oncology clinical trial program to give as many patients as possible access to innovative treatments. The program strengthens translational, patient-centered research, supports the development of new trials, and streamlines study processes through standardized workflows and digital platforms. It also includes the establishment of a CCCZ Trial Center and the development of a Zurich study network in collaboration with regional hospitals. CCCZ works closely with the Swiss Cancer Institute.

Clinical Trial Program Team

Alexandre Theocharides 2035

Prof. Dr. med. Alexandre Theocharides, Director CCCZ Clinical Trials Program, University Hospital Zurich, Department of Medical Oncology and Hematology, alexandre.theocharides@usz.ch

MA Foto Joy Meli

Joy Meli, CCCZ Clinical Trial Program, Clinical Research Nurse, University Hospital Zurich, joy.meli@usz.ch

Contact

Comprehensive Cancer Center Zurich
University Hospital Zurich
Raemistrasse 100
8091 Zurich

Tel. +41 44 255 44 00
Mail: CCCZ.ClinicalTrials@usz.ch

Monday – Friday from 8.00 – 11.30 a.m. and 12.30 – 5.00 p.m.